Solutions
About Us
Insights
Careers
Contact us
Contact Us
Customer Support
Customer Support

Conus medullaris termination: Assessing safety of spinal anesthesia in the L2-L3 interspace. Paul JE, Udovic LA, Oman K, Kim T, Bernstein L, Matteliano L, Singh N, Caldwell A, Vanniyasingam T, Thabane L. Acta Anaesthesiol Scand. 2025

Real-world therapy and persistence of patients with neovascular age-related macular degeneration and diabetic retinopathy or diabetic macular edema: a German claims data analysis. Krieger J, Cox O, Flacke JP, Beilschmidt L, Mueller S, Maywald U, Koss MJ. Graefes Arch Clin Exp Ophthalmol. 2025

PCV20 for the prevention of invasive pneumococcal disease in the Mexican pediatric population: A cost-effectiveness analysis. Huerta JL, Ta A, Vinand E, Torres GI, Wannaadisai W, Huang L. Hum Vaccin Immunother. 2025

Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study. Merseburger AS, Dornstauder E, Ohlmann CH, Aprikian A, Junker S, Hahn P, Chilelli A, Stoelzel M, Serikoff A, Spitzer SG. Adv Ther. 2025

Elranatamab versus physician’s choice of treatment in patients with triple-class exposed/refractory multiple myeloma: an updated matching-adjusted indirect comparison. Mol I, Hu Y, LeBlanc TW, Cappelleri JC, Chu H, Nador G, Aydin D, Cruz IP, Hlavacek P. J Comp Eff Res. 2025

Real-world avelumab first-line maintenance in advanced urothelial carcinoma: systematic review and meta-analysis. Barthélémy P, Musat MG, Moradian H, Kearney M. Future Oncol. 2025

A Cost-Effectiveness Analysis for Avelumab as a First-Line Maintenance Treatment of Advanced Urothelial Carcinoma in the Netherlands. Smalbrugge D, Walsteijn T, de Feijter J, Suelmann B, Kearney M, Benedict A, Kapetanakis V, van Beekhuizen S. Oncol Ther. 2025

Epidemiology, patient management, and survival outcomes in resected patients with non-metastatic non-small cell lung cancer: a nationwide real-world study. Renaud S, Casabianca P, Diez-Andreu P, Chartier M, Gaudin AF, Bugnard F, Bénard S, Cotté FE, Chouaid C. BMC Cancer. 2025

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort study. Batyrbekova N, Hultcrantz M, Ravn Landtblom A, Szulkin R, Dickman PW, Andersson TM, Syriopoulou E. Br J Haematol. 2025

Real-world characteristics and outcomes of patients with multiple myeloma treated with belantamab mafodotin: a German claims data study. Luna J, d’Estrube T, Jacobsen A, Lehne M, Wellmann-Pichler B, Mevius A, Dornig S. Ann Hematol. 2025